Caliway Biopharmaceuticals (TWSE: 6919) announced two clinical milestones for its fat-reduction drug CBL-514, according to a company press release dated ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE